Advertisement

Topics

Biotime Expands & Advances Ophthalmology Portfolio

07:00 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Expanded Exclusive, Global License to RPE and Photoreceptor Cells for Use in All Eye Disorders Data Presented at International Society for Stem Cell Research (ISSCR) Conference T...

Other Sources for this Article

Investor Contact:
EVC Group, Inc.
Michael Polyviou, 646-445-4800
mpolyviou@evcgroup.com;
or
Doug Sherk, 646-445-4800
dsherk@evcgroup.com
or
Media Contact:
JQA Partners, Inc.
Jules Abraham, 917-885-7378
jabraham@jqapartners.com

NEXT ARTICLE

More From BioPortfolio on "Biotime Expands & Advances Ophthalmology Portfolio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...